Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IDEAYA Biosciences, Inc. - Common Stock (NQ:IDYA)

30.27 -1.25 (-3.97%)
Streaming Delayed Price Updated: 12:18 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IDEAYA Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Recap: IDEAYA Biosciences Q4 Earnings ↗
 
Via Benzinga
News headline image
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts ↗
 
Via Benzinga
News headline image
Goldman Sachs Maintains Buy Rating for IDEAYA Biosciences: Here's What You Need To Know ↗
 
Via Benzinga
IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/24
Via Investor Brand Network
IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/19
Via Investor Brand Network
News headline image
Chart Of The Day: IDEAYA Biosciences - Oncology Biomedicine ↗
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using... 
Via Talk Markets
News headline image
Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know ↗
 
Via Benzinga
News headline image
8 Analysts Have This to Say About IDEAYA Biosciences ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for IDEAYA Biosciences ↗
 
Via Benzinga
News headline image
Why Ideaya Biosciences Stock Is Plummeting Today ↗
Ideaya stock is getting hit hard following a recent press release from the company. 
Via The Motley Fool
News headline image
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. 
Via Benzinga
News headline image
Why IDEAYA Biosciences Stock Is Falling During Wednesday's Session ↗
Ideaya Biosciences Inc (NASDAQ: IDYA) shares are trading lower by 11.6% to $24.10 Wednesday morning after the company priced an underwritten public offering of common stock and pre-funded warrants. 
Via Benzinga
News headline image
Where IDEAYA Biosciences Stands With Analysts ↗
 
Via Benzinga
News headline image
7 Analysts Have This to Say About IDEAYA Biosciences ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for IDEAYA Biosciences ↗
 
Via Benzinga
News headline image
Alphabet, Texas Instruments, CoStar Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Adobe To Rally Over 14%? Here Are 10 Other Analyst Forecasts For Tuesday ↗
RBC Capital boosted the price target for CareTrust REIT, Inc. (NYSE: CTRE) from $19 to $23. RBC Capital analyst Michael Carroll upgraded the stock from Sector Perform to Outperform. CareTrust REIT... 
Via Benzinga
News headline image
Top 5 Health Care Stocks That May Fall Off A Cliff ↗
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
News headline image
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Analyst Expectations for IDEAYA Biosciences's Future ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗
 
Via Benzinga
News headline image
Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter ↗
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023 ↗
 
Via Benzinga
Ideaya Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 5/11
Via Investor Brand Network
News headline image
Recap: IDEAYA Biosciences Q1 Earnings ↗
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
IDEAYA Biosciences: Q1 Earnings Insights ↗
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment. 
Via Benzinga
IDEAYA Biosciences Inc. (NASDAQ: IDYA) Leading the Way in Monday Trading Based on Percentage Gain
Via Investor Brand Network
News headline image
Nasdaq Turns Lower Ahead Of Big Week For Tech ↗
The Nasdaq Composite Index has begun to slip deeper into the red ahead of this week's slew of Big Tech earnings. 
Via Talk Markets
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.